Clinical Trial Update: Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating dose escalation of allogeneic adipose-derived stromal/stem cells for the treatment of Crohn's fistula; recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Allogeneic adipose-derived stromal/stem cells

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: RECRUITING